Episode of harmful use of dissociative drugs including ketamine or PCP

Definition

An episode of use of a dissociative drug, including Ketamine and PCP, that has caused damage to a person’s physical or mental health or has resulted in behaviour leading to harm to the health of others. Harm to health of the individual occurs due to one or more of the following: (1) behaviour related to intoxication; (2) direct or secondary toxic effects on body organs and systems; or (3) a harmful route of administration. Harm to health of others includes any form of physical harm, including trauma, or mental disorder that is directly attributable to behaviour due to intoxication with a dissociative drug, including Ketamine and PCP, on the part of the person to whom the diagnosis of single episode of harmful use applies. This diagnosis should not be made if the harm is attributed to a known pattern of use of dissociative drugs, including Ketamine and PCP.

Exclusions

• Dissociative drug dependence including ketamine or PCP (6C4D.2)
• Harmful pattern of use of dissociative drugs, including ketamine or PCP (6C4D.1)

Also indexed as

Nearby in Disorders due to use of dissociative drugs including ketamine or phencyclidine (PCP)

• 6C4D.1Harmful pattern of use of dissociative drugs, including ketamine or PCP
• 6C4D.2Dissociative drug dependence including ketamine or PCP
• 6C4D.3Dissociative drug intoxication including Ketamine or PCP
• 6C4D.4Dissociative drug-induced delirium including ketamine or PCP
• 6C4D.5Dissociative drug-induced psychotic disorder including ketamine or PCP
• 6C4D.6Certain specified dissociative drug-induced mental or behavioural disorders, including ketamine or phencyclidine (PCP)
• 4B4YOther specified diseases of the immune system
• 4B4ZDiseases of the immune system, unspecified